By Melissa Lipman ( July 1, 2010, 1:40 PM EDT) -- A European court affirmed on Thursday a 2005 European Commission decision that AstraZeneca PLC abused its market dominance and the patent system in order to block generic competitors for its blockbuster ulcer drug Losec, but trimmed €7.5 million ($9.4 million) from the drugmaker's fine for hindering parallel imports....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.